Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Chronic myeloid leukemia R-HSA-9680350 map05220 vorinostat 5311 drug-path
Complement and coagulation cascades R-HSA-114591 map04610 vorinostat 5311 drug-path
Glioma Q9NZM4 map05214 alvespimycin 43815 drug-path
Antigen processing and presentation R-HSA-1236975 map04612 alvespimycin 43815 drug-path
Olfactory transduction R-HSA-9751605 map04740 alvespimycin 43815 drug-path
Focal adhesion R-HSA-354113 map04510 alvespimycin 43815 drug-path
Pancreatic cancer R-HSA-9700206 map05212 alvespimycin 43815 drug-path
Prostate cancer R-HSA-2990872 map05215 alvespimycin 43815 drug-path
Vascular smooth muscle contraction R-HSA-445355 map04270 alvespimycin 43815 drug-path
Natural killer cell mediated cytotoxicity R-HSA-5218921 map04650 alvespimycin 43815 drug-path
Hematopoietic cell lineage R-HSA-173752 map04640 alvespimycin 43815 drug-path
PPAR signaling pathway R-HSA-168638 map03320 alvespimycin 43815 drug-path
Alzheimer's disease R-HSA-1643685 0 alvespimycin 43815 drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 alvespimycin 43815 drug-path
Huntington's disease R-HSA-1643685 0 alvespimycin 43815 drug-path
Jak-STAT signaling pathway R-HSA-168638 map04630 alvespimycin 43815 drug-path
Parkinson's disease R-HSA-1643685 0 alvespimycin 43815 drug-path
Cardiac muscle contraction R-HSA-397014 map04260 alvespimycin 43815 drug-path
Cytokine-cytokine receptor interaction R-HSA-6788467 map04060 alvespimycin 43815 drug-path
Ribosome R-HSA-5368277 map03010 alvespimycin 43815 drug-path